Azenta, Inc. (AZTA)
NASDAQ: AZTA · Real-Time Price · USD
30.75
+0.24 (0.79%)
At close: Jun 26, 2025, 4:00 PM
30.77
+0.02 (0.07%)
After-hours: Jun 26, 2025, 4:00 PM EDT
Revenue by Product
Fiscal year is October - September.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2018 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | 2018 - 2020 |
Sample Management Solutions | 326.61M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Sample Management Solutions Growth | 5.26% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Life Sciences Products | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Life Sciences Products Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Life Sciences Services | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Life Sciences Services Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Multiomics | 259.43M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Multiomics Growth | 3.81% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Core Products | 200.67M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Core Products Growth | 3.32% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Sample Repository Solutions | 125.94M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Sample Repository Solutions Growth | 8.49% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
B Medical | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
B Medical Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is October - September.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2018 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | 2018 - 2020 |
North America | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
North America Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
China | 57.34M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
China Growth | 4.37% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Asia Pacific/ Other | 34.66M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Asia Pacific/ Other Growth | -18.51% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Africa | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Africa Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
United Kingdom | 31.99M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
United Kingdom Growth | 19.09% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Rest of Europe | 103.67M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Rest of Europe Growth | 10.14% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
United States | 370.63M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
United States Growth | 3.34% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other
Fiscal year is October - September.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2018 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | 2018 - 2020 |
Sample Management Solutions Adjusted Operating Income | 20.42M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Sample Management Solutions Adjusted Operating Income Growth | -416.61% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Multiomics Adjusted Operating Income | -9.20M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Multiomics Adjusted Operating Income Growth | 83.89% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
B Medical Systems Adjusted Operating Income | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
B Medical Systems Adjusted Operating Income Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Life Sciences Product Adjusted Operating Income | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Life Sciences Product Adjusted Operating Income Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Life Sciences Services Adjusted Operating Income | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Life Sciences Services Adjusted Operating Income Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Organic Revenue Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|